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LETTERS

Severe
Pneumomediastinum
Complicating
EBUS-TBNA
To the Editor:
Pneumomediastinum infrequently complicates diagnostic
bronchoscopy. Increased airway
or alveolar pressure results in air
leaks to the mediastinum through
existing or induced defects.
Excessive cough, recurrent episodes of increased abdominal
pressure, vomiting, or sneezing
can all induce spontaneous pneumomediastinum. Less commonly
it has been documented with lung
or neck infections, esophageal or
tracheal tears, and rapid increases
in altitude such as during plane
ﬂights or scuba diving, with
mechanical ventilation, substance
abuse, and after bronchoscopy.
Pneumomediastinum may be, but
is not always, associated with
pneumothorax.
We recently evaluated a 63year-old male patient with a
2-day history of hemoptysis and
a left upper-lobe lung mass
with hilar adenopathy and a
postobstructive process. Flexible
white
light
bronchoscopy
showed a normal airway except
for an occluded left upper-lobe
bronchus with sparing of the
lingula. Multiple forceps biopsies
were obtained from the apparent
endobronchial lesion. Endobronchial ultrasound (EBUS)Disclosure: There is no conﬂict of interest or
other disclosures.
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the terms of the Creative Commons Attribution-Non Commercial-No Derivatives
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work cannot be changed in any way or
used commercially.
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guided lymph node biopsies were
obtained from stations 4R, 4L,
7, and 11L. During the procedure there were no complications
and no bleeding. The pathology
report revealed moderately differentiated squamous cell cancer
from only the left upper-lobe
endobronchial biopsies.
One day after discharge the
patient returned to the emergency
room with recurrent severe cough
and chest and neck pain associated with increasing swelling of
the neck. There was no hemodynamic or respiratory compromise.
CT scan of the chest and neck
(Fig. 1) to investigate the neck
and chest “swelling” showed
pneumomediastinum with extensive subcutaneous emphysema
with no apparent pneumothorax.
The patient was treated with
cough suppressants, analgesics,
and stool softeners, along with
oxygen supplementation through
a nasal cannula. The pneumomediastinum and subcutaneous
emphysema resolved without any
other intervention. The pneumomediastinum was felt to be iatrogenic and was most likely related
to the bronchoscopic procedure.
Bronchoscopy with endobronchial
ultrasound–guided
transbronchial needle aspiration
(EBUS-TBNA) is considered to
be a very safe procedure and is
certainly less invasive than
mediastinoscopy or percutaneous
needle biopsy. It has been
increasingly utilized for the diagnosis of sarcoidosis, for unexplained mediastinal adenopathy,
and for lung cancer staging.
Complications from EBUSTBNA are rare. Focal tracheal
stenosis secondary to intramural
hematoma following EBUSTBNA has been reported.1 Barotrauma after ablation techniques
has previously been seen.2

Pneumothorax was reported in
0.03% (2/7345) of procedures in a
survey of 455 facilities in Japan.3
There was no pneumomediastinum reported. Hemorrhagic
and infectious complications were
the most common. A review of
the AQuIRE registry for complications revealed no reported cases
of pneumomediastinum, with a
rate of pneumothorax of 0.2%
reported among patients who did
not undergo transbronchial biopsies.4 In a comprehensive review
of all published articles on endosonography of the mediastinum
(EBUS or EUS or their combination) from 1995 to 2012, von
Bartheld et al5 did not report
any case of pneumomediastinum. Most complications
from this procedure were infectious. EUS was the main risk
factor for complications, with 18
of 23 serious complications being
observed in this group, compared with EBUS.
To our knowledge, this is the
ﬁrst case of pneumomediastinum
that is associated with EBUSTBNA. It is unlikely that the
positive pressure ventilation used
during the procedure caused the
pneumomediastinum. The procedure was performed through the
LMA utilizing general anesthesia
but with spontaneous ventilation
and 5 cm water pressure support.
In addition, the patient presented
with pneumomediastinum >24
hours after the procedure, which
makes it less likely to be related to
the positive pressure and more
likely related to a defect created by
the procedure in the bronchial
wall and exacerbated by cough.
Although the direct cause of the
pneumomediastinum cannot be
certainly established, whether
related to the TBNA or to the
endobronchial biopsy, we would
like to alert other bronchoscopists
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FIGURE 1. CT scan of the chest and neck showing pneumomediastinum and subcutaneous air (arrows). Lung mass in
the left upper lobe (asterisk).

of the potential rare complication
and stress upon the fact that
conservative therapy should be the
ﬁrst line of treatment. Treatment
should be aimed at decreasing
intrathoracic pressure spikes by
reducing coughing and straining.
Oxygen therapy might hasten
reabsorption of the subcutaneous
nitrogen bubble as it does to a
pneumothorax.
Yousef Shweihat, MBBS,
FCCP, DAABIP*w
James D. Perry, III, DO*w
Nancy Munn, MD, FCCP*w
*Veterans Aﬀairs Medical Center
wMarshall University
Huntington, WV
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Use of Self-expanding
Metallic Airway
Stents in Tracheobronchomalacia
To the Editor:
Airway stents have evolved
in
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applications. Predominantly used
in the treatment of central airway
obstruction, the 2 types of stents,
silicone and metal (fully covered,
partially covered, and uncovered), oﬀer diﬀerent advantages
and disadvantages. Silicone
stents suﬀer from mucus plugging, high rate of migration, and
inability to conform to tortuous
airways, and require rigid bronchoscopy for deployment. However, they are less expensive and
are relatively easy to remove.
Self-expanding metallic airway
stents (SEMAS) have less mucus
plugging, less incidence of migration, better conform to tortuous
airways, and can be easily
deployed using ﬂexible or rigid
bronchoscopy. However, when
left for a prolonged period of
time, SEMAS are signiﬁcantly
harder to remove, with increased
potential for complications.1,2
Because of these considerations,
FDA has recommended that silicone stents be used as ﬁrst line
in the treatment of benign airway disease, and SEMAS as the
last resort or for palliation of
malignant airway obstruction.3
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